Inventiva, a clinical-stage biopharmaceutical company, has announced promising results from the LEGEND trial, which evaluated the combination of lanifibranor and empagliflozin for treating metabolic dysfunction-associated steatohepatitis (MASH) in patients with type-2 diabetes (T2D). These findings will be presented during an oral plenary session at the upcoming EASL Steatotic Liver Disease (SLD) Summit 2025 in Portugal.
The AHA Sessions 2024 were scheduled to be held from November 16th to 18th at the McCormick Place Convention Center in Chicago, IL. This event was brought together healthcare professionals, researchers, and experts from around the world to share and discuss the latest advancements and breakthroughs in cardiovascular science.
The 60th European Association for the Study of Diabetes (EASD) Annual Meeting held on September 9-13, 2024 in Madrid. The EASD Annual Meeting provided the perfect setting to exchange ideas and network with peers from all over the world, connecting the global diabetes community, sharing groundbreaking diabetes science and research, and offering educational opportunities.
The world’s leading cardiology experts convened in London, UK and online at the European Society of Cardiology 2024 congress (ESC 2024, 30 August – 2 September). ESC 2024 aimed to transform patient care and advance the field through ground-breaking research, pioneering technologies, and collaborative initiatives.
From June 21–24, the American Diabetes Association (ADA) hosted the 84th Scientific Sessions in Orlando, FL. The ADA’s Scientific Sessions is the world’s largest diabetes meeting, convening more than 11,000 leading physicians, scientists, researchers and health care professionals from around the globe. The leading diabetes scientific sessions meeting presented groundbreaking data on key topics including Obesity, Technology, AI Health and the latest in diabetes innovation.
The 33rd European Meeting on Hypertension and Cardiovascular Renal Protection (ESH 2024), which was held in Berlin at the Estrel Congress Centre (ECC), on May 31-June 3, 2024. The 2024 Berlin Meeting presented the ESH conference in a new and fresh format with a streamlined range of session types. 2024 ESH Clinical Practice Guidelines for Hypertension Management and Hypertension & Cardiorenal Diseases were the 2 main session pathways of the meeting.
